The effect of vitamin D supplementation on blood pressure in patients with elevated blood pressure and vitamin D deficiency: A randomized, double-blind, placebo-controlled trial

Blood Pressure Monitoring

Volumn 20, Issue 2, 2015, Pages 83-91

  Mozaffari Khosravi, Hassan ^a   Loloei, Saba ^a   Mirjalili, Mohammad Reza ^a   Barzegar, Kazem ^a  

^a SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

blood pressure; cholecalciferol; hypertension; vitamin D deficiency

Indexed keywords

25 HYDROXYVITAMIN D; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM; COLECALCIFEROL; DIURETIC AGENT; MAGNESIUM; PARATHYROID HORMONE; PHOSPHORUS; PLACEBO; POTASSIUM; SODIUM; VITAMIN D; VITAMIN;

ABDOMINAL OBESITY; ADULT; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET SUPPLEMENTATION; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; ELEVATED BLOOD PRESSURE; FEMALE; HUMAN; HYPERTENSION; IRAN; LABORATORY TEST; MALE; MEAN ARTERIAL PRESSURE; MERCURY SPHYGMOMANOMETER; OUTPATIENT; PRIORITY JOURNAL; PULSE PRESSURE; RANDOMIZED CONTROLLED TRIAL; SERUM; SYSTOLIC BLOOD PRESSURE; VITAMIN D DEFICIENCY; BLOOD; DRUG EFFECTS; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; TIME;

ADMINISTRATION, ORAL; ADULT; BLOOD PRESSURE; CHOLECALCIFEROL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; TIME FACTORS; VITAMIN D DEFICIENCY; VITAMINS;

EID: 84925860334     PISSN: 13595237     EISSN: 14735725     Source Type: Journal    
DOI: 10.1097/MBP.0000000000000091     Document Type: Article

References (65)

1. Mittal BV, Singh AK. Hypertension in the developing world: challenges and opportunities. Am J Kidney Dis 2010; 55: 590-598
2. Whelton PK. Epidemiology of hypertension. Lancet 1994; 344: 101-106
3. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-1252
4. Druss BG, Marcus SC, Olfson M, Tanielian T, Elinson L, Pincus HA. Comparing the national economic burden of five chronic conditions. Health Aff (Millwood) 2001; 20: 233-241
5. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365: 217-223
6. Hatmi ZN, Tahvildari S, Gafarzadeh Motlag A, Sabouri Kashani A. Prevalence of coronary artery disease risk factors in Iran: a population based survey. BMC Cardiovasc Disord 2007; 7: 32
7. Raymond JL, Couch SC. Medical nutrition therapy for cardiovascular disease. In: Mahan LK, Escott-Stump S, Raymond JL, editors. Krause's food and the nutrition care process. 13th ed. USA: Elsevier; 2012. pp. 742-781
8. Naber CK, Siffert W. Genetics of human arterial hypertension. Minerva Med 2004; 95: 347-356
9. Suter PM, Sierro C, Vetter W. Nutritional factors in the control of blood pressure and hypertension. Nutr Clin Care 2002; 5: 9-19
10. Bouillon R, Carmeliet G, Verlinden L, van Etten E, Verstuyf A, Luderer HF, et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 2008; 29: 726-776
11. Kienreich K, Grubler M, Tomaschitz A, Schmid J, Verheyen N, Rutters F, et al. Vitamin D, arterial hypertension &cerebrovascular disease. Indian J Med Res 2013; 137: 669-679
12. Muscogiuri G, Sorice GP, Ajjan R, Mezza T, Pilz S, Prioletta A, et al. Can vitamin D deficiency cause diabetes and cardiovascular diseases?. Present evidence and future perspectives. Nutr Metab Cardiovasc Dis 2012; 22: 81-87
13. Vaidya A, Forman JP. Vitamin D and hypertension: current evidence and future directions. Hypertension 2010; 56: 774-779
14. Calvo MS, Whiting SJ, Barton CN. Vitamin D intake: a global perspective of current status. J Nutr 2005; 135: 310-316
15. Holick MF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 2006; 81: 353-373
16. Hashemipour S, Larijani B, Adibi H, Javadi E, Sedaghat M, Pajouhi M, et al. Vitamin D deficiency and causative factors in the population of Tehran. BMC Public Health 2004; 4: 38
17. Forman JP, Curhan GC, Taylor EN. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension among young women. Hypertension 2008; 52: 828-832
18. Forman JP, Giovannucci E, Holmes MD, Bischoff-Ferrari HA, Tworoger SS, Willett WC, Curhan GC. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 2007; 49: 1063-1069
19. Hintzpeter B, Mensink GB, Thierfelder W, Müller MJ, Scheidt-Nave C. Vitamin D status and health correlates among German adults. Eur J Clin Nutr 2008; 62: 1079-1089
20. Hyppönen E, Boucher BJ, Berry DJ, Power C. 25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age: a cross-sectional study in the 1958 British Birth Cohort. Diabetes 2008; 57: 298-305
21. Judd SE, Nanes MS, Ziegler TR, Wilson PW, Tangpricha V. Optimal vitamin D status attenuates the age-Associated increase in systolic blood pressure in white Americans: results from the third National Health and Nutrition Examination Survey. Am J Clin Nutr 2008; 87: 136-141
22. Martins D, Wolf M, Pan D, Zadshir A, Tareen N, Thadhani R, et al. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 2007; 167: 1159-1165
23. Rostand SG. Ultraviolet light may contribute to geographic and racial blood pressure differences. Hypertension 1997; 30 (Pt 1): 150-156
24. Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey. Am J Hypertens 2007; 20: 713-719
25. Stamler J, Stamler R, Neaton JD. Blood pressure, systolic and diastolic, and cardiovascular risks. US population data. Arch Intern Med 1993; 153: 598-615
26. Borges AC, Feres T, Vianna LM, Paiva TB. Effect of cholecalciferol treatment on the relaxant responses of spontaneously hypertensive rat arteries to acetylcholine. Hypertension 1999; 34 (Pt 2): 897-901
27. Borges AC, Feres T, Vianna LM, Paiva TB. Recovery of impaired K+ channels in mesenteric arteries from spontaneously hypertensive rats by prolonged treatment with cholecalciferol. Br J Pharmacol 1999; 127: 772-778
28. Feres T, Vianna LM, Paiva AC, Paiva TB. Effect of treatment with vitamin D3 on the responses of the duodenum of spontaneously hypertensive rats to bradykinin and to potassium. Br J Pharmacol 1992; 105: 881-884
29. Goel RK, Lal H. Role of vitamin D supplementation in hypertension. Indian J Clin Biochem 2011; 26: 88-90
30. Judd SE, Raiser SN, Kumari M, Tangpricha V. 1, 25-Dihydroxyvitamin D3 reduces systolic blood pressure in hypertensive adults: a pilot feasibility study. J Steroid Biochem Mol Biol 2010; 121 (1-2): 445-447
31. Krause R, Bühring M, Hopfenmüller W, Holick MF, Sharma AM. Ultraviolet B and blood pressure. Lancet 1998; 352: 709-710
32. Lind L, Wengle B, Wide L, Ljunghall S. Reduction of blood pressure during long-Term treatment with active vitamin D (alphacalcidol) is dependent on plasma renin activity and calcium status. A double-blind, placebocontrolled study. Am J Hypertens 1989; 2: 20-25
33. Pfeifer M, Begerow B, Minne HW, Nachtigall D, Hansen C. Effects of a shortterm vitamin D3 and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol Metab 2001; 86: 1633-1637
34. Margolis KL, Ray RM, Van Horn L, Manson JE, Allison MA, Black HR, et al. Women's Health Initiative Investigators. Effect of calcium and vitamin D supplementation on blood pressure: the Women's Health Initiative Randomized Trial. Hypertension 2008; 52: 847-855
35. Orwoll ES, Oviatt S. Relationship of mineral metabolism and long-Term calcium and cholecalciferol supplementation to blood pressure in normotensive men. Am J Clin Nutr 1990; 52: 717-721
36. Pan WH, Wang CY, Li LA, Kao LS, Yeh SH. No significant effect of calcium and vitamin D supplementation on blood pressure and calcium metabolism in elderly Chinese. Chin J Physiol 1993; 36: 85-94
37. Scragg R, Khaw KT, Murphy S. Effect of winter oral vitamin D3 supplementation on cardiovascular risk factors in elderly adults. Eur J Clin Nutr 1995; 49: 640-646
38. Moradzadeh K, Larijani B, Keshtkar A, Hossein-Nezhad A, Rajabian R, Nabipour I. Normative values of vitamin D among Iranian population: a population based study. Int J Osteoporos Metab Disord 2008; 1: 8-15
39. Mozaffari-Khosravi H, Hosseinzadeh-Shamsi-Anar M, Salami MA, Hadinedoushan H, Mozayan MR. Effects of a single post-partum injection of a high dose of vitamin D on glucose tolerance and insulin resistance in mothers with first-Time gestational diabetes mellitus. Diabet Med 2012; 29: 36-42
40. Mozaffari-Khosravi H, Nabizade L, Yassini-Ardakani SM, Hadinedoushan H, Barzegar K. The effect of 2 different single injections of high dose of vitamin D on improving the depression in depressed patients with vitamin D deficiency: a randomized clinical trial. J Clin Psychopharmacol 2013; 33: 378-385
41. Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 2008; 87: 1080S-1086S
42. Kirkendall WM, Feinleib M, Freis ED, Mark AL. Recommendations for human blood pressure determination by sphygmomanometers. Subcommittee of the AHA Postgraduate Education Committee. Hypertension 1981; 3: 510A-519A
43. Heymsfield SB, Baumgartner RN. Body composition and anthropometry. In: Shils ME, Shike M, Ross CA, Caballero B, Cousins RJ, editors. Modern nutrition in health and disease. 10th ed. Philadelphia: Lippincott Williams &Wilkins; 2006. pp. 571-770
44. [No authors listed]. Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party. BMJ 1992; 304: 405-412
45. [No authors listed]. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. UK Prospective Diabetes Study Group. BMJ 1998; 317: 713-720
46. Dahlöf B, Devereux R, de Faire U, Fyhrquist F, Hedner T, Ibsen H, et al. The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group. Am J Hypertens 1997; 10 (Pt 1): 705-713
47. Dollery CT. An update on the Medical Research Council Hypertension Trial. J Hypertens Suppl 1987; 5: S75-S78
48. Bouillon R, Carmeliet G, Daci E, Segaert S, Verstuyf A. Vitamin D metabolism and action. Osteoporos Int 1998; 8 (Suppl 2): S13-S19
49. Sowers MR, Wallace RB, Lemke JH. The association of intakes of vitamin D and calcium with blood pressure among women. Am J Clin Nutr 1985; 42: 135-142
50. Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 1, 25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-Angiotensin system. J Clin Invest 2002; 110: 229-238
51. Li YC, Qiao G, Uskokovic M, Xiang W, Zheng W, Kong J. Vitamin D: a negative endocrine regulator of the renin-Angiotensin system and blood pressure. J Steroid Biochem Mol Biol 2004; 89-90 (1-5): 387-392
52. Resnick LM, Müller FB, Laragh JH. Calcium-regulating hormones in essential hypertension. Relation to plasma renin activity and sodium metabolism. Ann Intern Med 1986; 105: 649-654
53. Resnick LM, Nicholson JP, Laragh JH. Calcium metabolism in essential hypertension: relationship to altered renin system activity. Fed Proc 1986; 45: 2739-2745
54. Tomaschitz A, Pilz S, Ritz E, Grammer T, Drechsler C, Boehm BO, März W. Independent association between 1, 25-dihydroxyvitamin D, 25-hydroxyvitamin D and the renin-Angiotensin system: The Ludwigshafen Risk and Cardiovascular Health (LURIC) study. Clin Chim Acta 2010; 411 (17-18): 1354-1360
55. Ullah MI, Uwaifo GI, Nicholas WC, Koch CA. Does vitamin D deficiency cause hypertension?. Current evidence from clinical studies and potential mechanisms. Int J Endocrinol 2010; 2010: 579640
56. Bukoski RD, DeWan P, McCarron DA. 1, 25 (OH)2 vitamin D3 modifies growth and contractile function of vascular smooth muscle of spontaneously hypertensive rats. Am J Hypertens 1989; 2: 553-556
57. Cardus A, Panizo S, Encinas M, Dolcet X, Gallego C, Aldea M, et al. 1, 25-dihydroxyvitamin D3 regulates VEGF production through a vitamin D response element in the VEGF promoter. Atherosclerosis 2009; 204: 85-89
58. Mitsuhashi T, Morris RC Jr, Ives HE. 1, 25-dihydroxyvitamin D3 modulates growth of vascular smooth muscle cells. J Clin Invest 1991; 87: 1889-1895
59. Sugden JA, Davies JI, Witham MD, Morris AD, Struthers AD. Vitamin D improves endothelial function in patients with type 2 diabetes mellitus and low vitamin D levels. Diabet Med 2008; 25: 320-325
60. Talmor Y, Bernheim J, Klein O, Green J, Rashid G. Calcitriol blunts proatherosclerotic parameters through NFkappaB and p38 in vitro. Eur J Clin Invest 2008; 38: 548-554
61. Talmor Y, Golan E, Benchetrit S, Bernheim J, Klein O, Green J, Rashid G. Calcitriol blunts the deleterious impact of advanced glycation end products on endothelial cells. Am J Physiol Renal Physiol 2008; 294: F1059-F1064
62. Tarcin O, Yavuz DG, Ozben B, Telli A, Ogunc AV, Yuksel M, et al. Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects. J Clin Endocrinol Metab 2009; 94: 4023-4030
63. Wakasugi M, Noguchi T, Inoue M, Kazama Y, Tawata M, Kanemaru Y, Onaya T. Vitamin D3 stimulates the production of prostacyclin by vascular smooth muscle cells. Prostaglandins 1991; 42: 127-136
64. Brickman A, Nyby M, von Hungen K, Eggena P, Tuck M. Parathyroid hormone, platelet calcium, and blood pressure in normotensive subjects. Hypertension 1991; 18: 176-182
65. Hulter HN, Melby JC, Peterson JC, Cooke CR. Chronic continuous PTH infusion results in hypertension in normal subjects. J Clin Hypertens 1986; 2: 360-370